DataMeds AI, Inc. (MEDS) stock
MEDSNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.64−0.00 (-0.28%)
Close on Nov 17, 2026Market cap $1.96MP/E –Yield –
DataMeds AI ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
DataMeds AI's ebitda for the twelve months ending Sep 30, 2026 was -$40.21M. For fiscal 2025 it was -$90.54M.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$90.54M | – |
| FY2024 | Dec 31, 2024 | -$5.03M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$3.02M | – |
| Q2 FY2026 | Jun 30, 2026 | -$6.99M | – |
| Q1 FY2026 | Mar 31, 2026 | -$5.66M | – |
| Q4 FY2025 | Dec 31, 2025 | -$24.55M | – |
| Q3 FY2025 | Sep 30, 2025 | -$30.75M | – |
| Q2 FY2025 | Jun 30, 2025 | -$4.70M | – |
| Q1 FY2025 | Mar 31, 2025 | -$30.55M | – |
| Q4 FY2024 | Dec 31, 2024 | -$3.10M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.28M | – |
See a number that looks wrong?